Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Euro Medium Term Note Programme

3 Mar 2026 16:57

RNS Number : 1884V
Babcock International Group PLC
03 March 2026
 

3 March 2026

 

 

Babcock International Group PLC

 

Publication of Base Prospectus

 

The following base prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and is available for viewing:

 

The Prospectus dated 3 March 2026 relating to the Babcock International Group PLC £3,000,000,000 Euro Medium Term Note Programme.

 

 

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

 

To view the Prospectus, please paste the following URL into the address bar of your browser:

 

https://www.babcockinternational.com/investors/debt-investors/emtn-programme/

 

A copy of the Prospectus will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

For further information please contact:

 

Babcock International Group PLC

Andrew Gollan Samuel MacGregor

Director of Investor Relations Investor Relations Manager

Tel: +44 7936 039 004 Tel: +44 7730 753 159

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIJJMFTMTAMBJF
Date   Source Headline
6th Oct 20172:42 pmRNSAnna Stewart
20th Sep 20179:51 amRNSHolding(s) in Company
20th Sep 20177:00 amRNSTrading Update
8th Sep 201710:41 amRNSPublication of a Prospectus
17th Aug 201711:37 amRNSHolding(s) in Company
16th Aug 201711:54 amRNSDirector/PDMR Shareholding
13th Jul 20173:48 pmRNSResult of AGM
13th Jul 20177:00 amRNSAnnual General Meeting Trading Update
29th Jun 20177:00 amRNSContract Award
27th Jun 201712:32 pmRNSDirector/PDMR Shareholding
22nd Jun 201712:00 pmRNSDirector/PDMR Shareholding
20th Jun 201711:53 amRNSDirector/PDMR Shareholding
19th Jun 201710:53 amRNSDirector/PDMR Shareholding
15th Jun 20173:58 pmRNSDirector/PDMR Shareholding
13th Jun 20175:08 pmRNSNotice of AGM
7th Jun 20175:24 pmRNSHolding(s) in Company
7th Jun 20174:55 pmRNSDirector/PDMR Shareholding
7th Jun 20171:17 pmRNSDirector/PDMR Shareholding
1st Jun 201710:11 amRNSPublication of Final Terms
30th May 20175:23 pmRNSDirector/PDMR Shareholding
24th May 20173:43 pmRNSHolding(s) in Company
24th May 20177:00 amRNSFinal Results
19th May 20179:34 amRNSHolding(s) in Company
2nd May 20179:59 amRNSHolding(s) in Company
13th Apr 201710:09 amRNSHolding(s) in Company
13th Apr 20178:55 amRNSHolding(s) in Company
11th Apr 20179:26 amRNSHolding(s) in Company
3rd Apr 20177:00 amRNSPreferred bidder for Royal Navy support contract
29th Mar 20174:38 pmRNSHolding(s) in Company
27th Mar 20173:01 pmRNSDirector/PDMR Shareholding
27th Mar 20172:58 pmRNSDirector/PDMR Shareholding
27th Mar 201712:10 pmRNSDirector/PDMR Shareholding
27th Mar 20177:22 amRNSMagnox decommissioning contract
24th Mar 20179:54 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSRealignment Presentation
28th Feb 20177:00 amRNSTrading Update
24th Feb 20171:00 pmRNSHolding(s) in Company
15th Feb 201712:11 pmRNSHolding(s) in Company
9th Feb 20174:53 pmRNSHolding(s) in Company
7th Feb 20175:00 pmRNSDirector Declaration
3rd Feb 20175:23 pmRNSHolding(s) in Company
20th Jan 201710:01 amRNSDirector/PDMR Shareholding
5th Jan 20179:00 amRNSFOMEDEC Contract Award
12th Dec 20161:19 pmRNSDirector Declaration
28th Nov 20164:18 pmRNSHolding(s) in Company
28th Nov 201611:07 amRNSDirector/PDMR Shareholding
23rd Nov 20163:48 pmRNSHolding(s) in Company
23rd Nov 20162:56 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHalf-year Report
21st Nov 201611:13 amRNSContract Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.